Identification of 3-methoxy-4-hydroxy-5-hexaprenylbenzoic acid as a new intermediate in ubiquinone biosynthesis by Saccharomyces cerevisiae  by Goewert, Robert R. et al.
Volume 87, number 2 FEBS LETTERS March 1978 
IDENTIFICATION OF 3-METHOXY 4-HYDROXY -5HEXAPRENY LBENZOIC ACID AS 
A NEW INTERMEDIATE IN UBIQUINONE BIOSYNTHESIS BY 
SACCHAR OM YCES CEREVISIAE 
Robert R. GOEWERT, C. Jeffrey SIPPEL, Michael F. GRIMM and Robert E. OLSON 
Edward A. Doisy Department of Biochemistry, Saint Louis University School of Medicine, St. Louis, MO 63104, USA 
Received 3 January 1978 
1. Introduction 
Recent evidence indicates that there are major 
differences in the biosynthetic pathway of ubiquinone 
in prokaryotes as compared with eukaryotes [l-3] . 
3,4-Dihydroxy-5.hexaprenylbenzoic acid from a 
ubiquinone-deficient strain of Saccharomyces 
cerevtiiae was isolated [4], demonstrating that 
eukaryotes, unlike prokaryotes, hydroxylate 
4-hydroxy-5polyprenylbenzoic acid prior to decar- 
boxylation [4] . In addition, this protocatechuic acid 
derivative was found to accumulate in methionine 
auxotrophs of yeast when methionine is removed 
from the culture medium [S] . Using rat liver and 
heart mitochondrial preparations, both protocatechuic 
and vanillic acids can be prenylated in vitro [6] . 
Further, the prenylated protocatechuic acid was 
found to be converted to ubiquinone, suggesting this 
metabolite to be on a pathway to ubiquinone bio- 
synthesis in mammals. 
The purpose of this communication isto report 
the isolation and identification of 3-methoxy4- 
hydroxy-5-hexaprenylbenzoic acid from a mutant 
strain of S. cerevisiae that is unable to synthesize ubi- 
quinone-6. The accumulation of this prenylated 
vanillic acid in this mutant blocked in ubiquinone-6 
biosynthesis suggests hat this compound is an 
obligate intermediate on the major pathway to ubi- 
quinoned biosynthesis nS. cerevisiae. 
2. Materials and methods 
2 .I. Chemicals 
[methy!-3H]Methionine was purchased from 
Amersham-Searle at spec. act. 8.7 Ci/mmol. 
p-Hydroxy-[U-14C]benzoate was prepared by sodium 
fusion of D,L-[U-14C] tyrosine (435 &!i/mmol) 
purchased from New England Nuclear Co. p-Hydroxy- 
[ 7-14C] benzoate was prepared by Grignard reaction 
of p-bromophenylether with 14C02 (Amersham- 
Searle) followed by catalytic reduction to the product 
with HZ/palladium. 
3-Methoxy4-hydroxy-5nonaprenylbenzoic ac d
was synthesized by alkylation of vanillic acid with 
solanesol via BFs as a catalyst. 
2.2. Radiolabeling of yeast cultures 
Ubiquinone-deficient mutant of S. cerevisiae 
(strain 26I-I) was a gift from J. de Kok [7] . This 
strain was grown in the presence of radiolabeled 
p-hydroxybenzoate in liquid cultures of SD media 
(0.67% Difco Yeast nitrogen base without amino 
acids) with 2 .O% dextrose at 3 1 “C using a New 
Brunswick gyrorotary shaker. Cultures were grown 
several hours into stationary phase, harvested, washed 
with distilled HsO, then lyophilized. The lyophilized 
pellets were extracted with acetone, followed by a 
second extraction with acetone/diethyl ether (1: 1). 
The fractions were combined, the solvent removed, 
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and the remaining viscous material analyzed by thin- 
layer chromatography (TLC) using Brinkrnan silica 
gel G 0.25 mm plates. In a separate xperiment, 
20 mg of L-methionine were added to a 500 ml 
culture of SD media and strain 26H was allowed to 
grow to mid-log phase. The cells were harvested by 
centrifugation and resuspended in fresh media con- 
taining 5 mCi [methyE3H]methionine at the original 
concentration of total methionine and incubated 
for 3 h. The cells were prepared as before, lyophilized, 
extracted with diethyl ether, the solvent removed and 
the lipid extract analyzed by TLC. 
2.3. Analytical methods 
The presence of labeled radioactive intermediates 
was detected by scanning the developed TLC plates 
using a model 7201 Packard radiochromatogram 
scanner. Authentic metabolites in the biosynthetic 
pathway for ubiquinone were cochromatographed 
with both the initial crude lipid extract and in con- 
sequent purification steps. Radioactivity was measured 
in Bray’s mixture [8] using a Packard Tri-Carb 
scintillation counter with [14C]toluene as a standard. 
[methyZ-3H]Methionine was used as the tritium 
standard. Mass spectral analysis was performed by 
direct probe employing a LKB 9000 computer- 
interface mass spectrometer. 
3. Results and discussion 
When strain 26H was grown in the presence of the 
precursorp-hydroxy-[U-14C]benzoic acid approx. 14% 
label was found to be incorporated into a lipid inter- 
mediate (peak 3, fig. 1 A) more polar than 2-nona- 
prenylphenol but less polar than either 3,4-dihydroxy- 
5-nonaprenylbenzoic acid or 4-hydroxy5nonaprenyl- 
benzoic acid. The new compound was purified to 
constant specific activity (peak 3, fig.1 B) by TLC 
employing several different solvent systems. Similar 
results were obtained usingp-hydroxy-[7-14C]benzoic 
acid. Since this intermediate possessed a unique RF 
relative to other characterized ubiquinone inter- 
mediates, larger amounts of this strain were grown to 
isolate and characterize this compound. 
Strain 26H, 12 liters, was cultured in SD medium 
in the presence of 70 &i p-hydroxy-[7-r4C] benzoic 
acid. An oily material, 0.45 g, was obtained from dry 
wt 18.7 g yeast and found to contain radioactivity, 
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Fig.la. Radiochromatography of TLC plate (silica gel 
0.25 mm) of acetone/ether extract of yeast mutant 26H 
grown in the presence of p-hydroxy-[U-‘4C]benzoate 
developed with cyclohexane/ether/acetic a id (5O:SO:O.S). 
A strip counter was used. Markers are (1) p-HBA; (2) 
3,4-dihydroxy-S-nonaprenylbenzoate; (3) 3-methoxy4- 
hydroxyJ-nonaprenylbenzoate; (4) 2-nonaprenylphenol. 
lb. Radiochromatogram of TLC plate of purified 3-methoxy- 
4-hydroxy-5-hexaprenylbenzoate developed with benzene/ 
acetone (1: 1). Segments, 0.5 cm, were scraped and counted 
in a scintillation spectrometer. 
2 X 10’ dpm. The extracted material was dissolved in 
25 ml hexane and the volume reduced to 5 ml with 
N, which produced precipitation of unmetabolized 
labeled p-hydroxybenzoic acid and extraneous lipids. 
50% radioactivity was recovered in the hexane- 
soluble fraction with a 2.5-fold increase in specific 
activity. This hexane-soluble xtract was subjected to 
preparative TLC using 1 .O mm silica gel G plates 
developed with benzene/acetone (1: 1). 8% counts 
were recovered with 6-fold increase in specific activity 
as shown in table 1. Final purification was achieved 
using a 0.25 mm analytical TLC plate developed with 
ether/cyclohexane (8:2). Of intermediate, 32 pug was 
obtained, estimated from ultraviolet absorption using 
a molar extinction coefficient hgJ 2 17 nm, 
e = 22 000. 
In a similar experiment in which [metIzyl-3H] -
methionine was employed, 0.11% of the label was 
incorporated into the intermediate, which was sub- 
sequently purified 90-fold by TLC to constant specific 
radioactivity. These results indicate that this new 
intermediate contains both a C-7 carboxyl group and 
at least 1 methyl constituent. 
Synthetic 3-methoxy4-hydroxy-S-nonaprenyl- 
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Table 1 
Isolation of 3-methoxy4-hydroxy-5-hexaprenylbenzoate from cells of 
S. cerevisiae 26H 
Step lipid 
(mg) 
Radioact. 
(dem) 
Spec. act. 
(@m/n%) 
1. Acetone/Ether (1: 1) 
crude extract 450 2.0 x lo7 44 000 
2. Hexane-soluble 
reside 90 1.1 x lo7 116 666 
3. TLC 
benzene/acetone (1: 1) 1.3 9.0 x lo5 692 307 
4. TLC 
ether/cy clohexane (8 : 2) 0.032 2.6 x lo4 854 838 
benzoic acid was purified in a similar manner as the 
labeled intermediate and found to exhibit identical 
mobilities in three different solvent systems. Ultra- 
violet spectra for the natural and synthetic homologue 
were identical. Mass spectra were obtained for both 
the material and synthetic homologue. Both com- 
pounds produced the base peak m/e 69 corresponding 
to an ion produced by fragmentation of the isoprene 
side chain. A m/e 97 fragment, characteristic for 
vanillic acid [9] was the second most abundant ion in 
both spectra. The unstable tropylium ion, which 
formed with m/e 181, was readily decarboxylated to
yield a prominent peak m/e 137. The chromenylium 
ion, a major peak at m/e 235 was also observed to 
produce the decarboxylated fragment at m/e 191. 
Further proof of the structure of the natural com- 
pound was obtained from the mass pectrum of its 
methyl ester, prepared by treatment with diazo- 
methane. The molecular ion observed for this com- 
pound was m/e 590 corresponding toits calculated 
molecular weight. In addition, a major fragment m/e 
195 corresponding tothe methyl ester of the tro- 
phylium ion was also observed. 
From the evidence presented, we conclude that 
the mutant yeast strain 26H accumulates 4-methoxy- 
3-hydroxy&hexaprenylbenzoic acid when given 
p-hydroxybenzoate. This suggests hat the genetic 
block in this mutant is at the ‘decarboxylase level’. 
This finding also constitutes the first clear evidence 
that O-methylation precedes decarboxylation of the 
benzoate derivatives in the biosynthesis of ubiqui- 
none 6 in yeast. 
it is now clear that the pathway of ubiquinone 
biosynthesis n prokaryotic organisms differs from 
that in eukaryotic organisms [lo-121 . In prokaryotic 
organisms 4-hydroxy-5-polyprenylbenzoate is con- 
verted to the next common intermediate, i.e., 
6-methoxy-2-polyprenylphenol i  steps involving 
decarboxylation, hydroxylation and methylation. In 
eukaryotic organisms, the sequence ishydroxylation, 
methylation and finally ‘decarboxylation’. The 
mechanism of this ‘decarboxylation’ is known and a 
subject of continuing study in this laboratory. 
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